CARI Health, Inc.

Enabling personalized methadone dosing for patients with opioid use disorder.

  • Stage Prototype Ready
  • Industry Medical Devices and Equipment
  • Location San Diego, CA 92130, USA
  • Currency USD
  • Founded October 2021
  • Employees 3
  • Incorporation Type C-corp
  • Website carihealth.com

Company Summary

CARI is developing the CARI Health metabolic assessment system (CMAS) to deliver quantitative in vitro measurements via a fingerstick blood sample at point of care. Like a glucometer, but for methadone, CMAS will enable clinicians to make rapid personalized dosing adjustments so patients reach a stable dose safely. This is intended to increase treatment retention, which would increase clinic revenues and decrease total cost of care for payers.

Team

  • Founder and Chief Executive Officer (CEO)

    Seasoned senior executive, including sales leadership.
    Expert in building teams w/ right combination of skills and passion.
    Part of 7 exits, 6 acquisitions & 1 IPO (3 in a leadership position).
    15 consecutive years with P&L responsibilities.
    Built/led Sales, Client Development, Product, IT, HR and Finance teams.
    Led software and app product development teams/efforts.

  • Medical Consultant

    Dr. Carr He has been a general practitioner since 1991 and a Medical Director of an outpatient treatment program for opioid dependency since 2015.

    He holds a BA in Biochemical Sciences from Harvard College and an MD from Stanford Medical School with 2 years of PhD training in Cancer Biology. His internal medicine internship was completed at Mount Zion/UC SAN FRANSISCO and a year of internal medicine residency was completed at UC SAN DIEGO.

  • Technical Advisor

    Technology and Product professional in the Wearables and Medical Device spaces. Performed engineering roles in large public technology companies Intel and Qualcomm.
    Applied technology towards improved, inexpensive health and wellness for all. Senior positions in wearable and continuous glucose monitoring companies, large (Dexcom) and small (Biolinq), he now leads the product and technology implementation as the CTO for CARI Health.

  • VP, Product Development

    25 year career in developing and commercializing point of care solutions, including lateral flow assay development. Previously at Alere, Prometheus, ProcisDx, Lumos, and Cue Health.

Advisors

Starting a startup?

Join the world's largest startup network for guidance, tools, and fundraising opportunities.

Get Started for Free